InPractice Survey on the Treatment of Hypercholesterolemia

AstraZeneca

Status: Completed

Conditions: Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00523796

VN-NIS-0001 (Other Identifier)

NIS-CVN-CRE-2007/1

Details and patient eligibility

About

This is a multi-centre survey of patients who are currently on lipid-lowering pharmacological treatment. Data collection for each patient will take place at one visit.

Enrollment: 2,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject must be 18 years of age or older of either sex.
• Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Exclusion criteria

• Subjects who are unwilling or unable to provide informed consent.